Patient treated with pazopanib
| dc.contributor.author | Richter Igor | cs |
| dc.contributor.author | Dvořák Josef | cs |
| dc.date.accessioned | 2020-06-08T09:46:00Z | |
| dc.date.available | 02-55-2020 | en |
| dc.date.available | 2020-06-08T09:46:00Z | |
| dc.date.issued | 2019-01-01 | cs |
| dc.date.updated | 11-15-2020 | en |
| dc.format.extent | 3 | cs |
| dc.identifier.issn | 1804-5871 | cs |
| dc.identifier.uri | https://dspace.tul.cz/handle/15240/156242 | |
| dc.language.iso | cze | cs |
| dc.publisher | We Make Media, s.r.o. | cs |
| dc.publisher.city | Praha | cs |
| dc.relation.ispartof | Renal Cancer News | en |
| dc.relation.ispartofseries | 0 | cs |
| dc.subject | renal cell cancer | cs |
| dc.subject | inhibitors of angiogenesis | cs |
| dc.subject | pazopanib | cs |
| dc.subject | first line therapy | cs |
| dc.subject | case study | cs |
| dc.title | Patient treated with pazopanib | en |
| dc.title | Pacient léčený pazopanibem | cs |
| local.citation.epage | 8-10 | cs |
| local.citation.spage | 8-10 | cs |
| local.identifier.publikace | 6950 | |
| local.relation.issue | 1 | cs |